WebAug 12, 2013 · “Licensed Patents” means all patents and patent applications in the Territory which cover Captisol and which now or at any time during the Term are owned by or licensed to CyDex or any CyDex Affiliate with the right to sublicense, including any and all extensions, renewals, continuations, substitutions, continuations-in-part, divisions, … WebLigand and SQ Innovation Enter into Exclusive Worldwide Captisol® This novel furosemide combination product is currently under investigation and is not approved by the FDA. Our Product A New Era Our Company Stay Updated
SUPPLY AGREEMENT Ligand Pharmaceuticals Incorporated
WebKansas Higuchi Biosciences Center .The technology of Captisol is used to address the limitations of drugs currently on the market. Captisol-enabled, FDA-approved drugs are sold by Pfizer, Bristol-Myers Squibb, and Baxter International. ... Captisol is an excipient used to improve solubility in certain medication injectable products, Captisol is ... WebNot all cyclodextrins are created equal. Captisol ® is a patent protected, uniquely modified cyclodextrin, whose chemical structure was rationally designed to enable the creation of new products by significantly … tgs4finance
LICENSE AGREEMENT BETWEEN CYDEX PHARMACEUTICALS, INC.
WebThe Captisol platform technology is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. The Pfenex … WebMar 23, 2024 · The Captisol ® platform technology is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Ligand’s Pelican Expression Technology ® is a robust, validated, cost-effective and scalable platform for recombinant protein production that is especially well-suited for ... WebIndustry Recognized Captisol Technology Brand - Captisol is recognized in the pharmaceutical industry as a powerful answer to the solubility challenges frequently faced by drug-development companies. CyDex' success is primarily based on solving drug formulation problems, particularly in the area of IV and topical formulations. tgs 410cb